Pan-Cancer Adaptive Immune Resistance as Defined by the Tumor Inflammation Signature (TIS): Results From the Cancer Genome Atlas (TCGA)
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-018-0367-1
Full Text
Open PDFAbstract
Available in full text
Date
June 22, 2018
Authors
Publisher
BMJ